Chester County News and Community Website
MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) announced it has completed enrollment for the Phase 3 liMeliGhT clinical trial evaluating OCU400, a gene therapy candidate for retinitis pigmentosa, a group …
Ocugen Completes Enrollment for Phase 3 Trial of OCU400 Gene Therapy Read More
WEST CHESTER, PA — The Chester County Health Department cited sanitation and food safety violations at two licensed food facilities during inspections conducted Thursday, including improper food storage, sanitation issues …
Chester County Health Inspectors Cite Violations at Two Food Facilities Read More
WEST CHESTER, PA — The Chester County Health Department reported multiple food safety violations following inspections conducted Wednesday at several licensed food establishments across the county.
Chester County Health Inspectors Report Violations at Four Food Facilities Read More
WEST CHESTER, PA — The Chester County Health Department reported multiple food safety and sanitation violations at three licensed food facilities following inspections conducted Tuesday, March 3.
Chester County Health Department Reports Violations at Three Food Facilities Read More
WAYNE, PA — Aclaris Therapeutics Inc. (Nasdaq: ACRS) said it has initiated a randomized, placebo-controlled Phase 1b proof-of-concept trial of its investigational antibody ATI-052 in patients with asthma, as it …
Aclaris Initiates Phase 1b Trial of ATI-052 in Asthma Read More
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) said it achieved the primary and all secondary endpoints in a Phase 3 trial of QTORIN 3.9% rapamycin gel for microcystic lymphatic …
Palvella Reports Phase 3 Success for QTORIN in Rare Skin Disorder Read More
WEST CHESTER, PA — The Chester County Health Department cited a school cafeteria, a West Chester meat market and an Oxford tavern for food safety and facility violations during inspections …
School, Tavern Cited in Latest Health Inspections Read More
MALVERN, PA — NexEos Bio Vision Health said that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to begin a Phase II/III clinical trial of …
NexEos Bio Vision Health Wins FDA Clearance for NTX-1024 Trial Read More
WASHINGTON, D.C. — Federal health officials this week announced a sweeping series of actions ranging from new drug approval guidance and Medicare fraud enforcement to more than $1 billion in …
HHS Rolls Out Health Push, Fraud Crackdown, Farm Plan Read More
WASHINGTON, D.C. — The Food and Drug Administration has released draft guidance outlining a new pathway to approve highly individualized treatments for ultra-rare diseases and has granted expedited approval to …
FDA Unveils Ultra-Rare Therapy Path, Fast-Tracks Lung Drug Read More